FR3120792B1 - Composition cosmétique destinée au traitement de l’hyperpigmentation cutanée et procédé de traitement utilisant ladite composition - Google Patents

Composition cosmétique destinée au traitement de l’hyperpigmentation cutanée et procédé de traitement utilisant ladite composition Download PDF

Info

Publication number
FR3120792B1
FR3120792B1 FR2102728A FR2102728A FR3120792B1 FR 3120792 B1 FR3120792 B1 FR 3120792B1 FR 2102728 A FR2102728 A FR 2102728A FR 2102728 A FR2102728 A FR 2102728A FR 3120792 B1 FR3120792 B1 FR 3120792B1
Authority
FR
France
Prior art keywords
treatment
composition
skin hyperpigmentation
cosmetic composition
intended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2102728A
Other languages
English (en)
Other versions
FR3120792A1 (fr
Inventor
Jean-Christophe Anton
Denis Marin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cryonove Pharma
Original Assignee
Cryonove Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR2102728A priority Critical patent/FR3120792B1/fr
Application filed by Cryonove Pharma filed Critical Cryonove Pharma
Priority to CN202280021925.7A priority patent/CN117157050A/zh
Priority to JP2023556513A priority patent/JP2024510614A/ja
Priority to MX2023010718A priority patent/MX2023010718A/es
Priority to US18/550,957 priority patent/US20240148425A1/en
Priority to EP22715023.2A priority patent/EP4308246A1/fr
Priority to BR112023018573A priority patent/BR112023018573A2/pt
Priority to PCT/EP2022/056600 priority patent/WO2022194810A1/fr
Publication of FR3120792A1 publication Critical patent/FR3120792A1/fr
Application granted granted Critical
Publication of FR3120792B1 publication Critical patent/FR3120792B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • A61B18/0218—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques with open-end cryogenic probe, e.g. for spraying fluid directly on tissue or via a tissue-contacting porous tip
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452—Skin
    • A61B2018/0047—Upper parts of the skin, e.g. skin peeling or treatment of wrinkles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87—Application Devices; Containers; Packaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/95—Involves in-situ formation or cross-linking of polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Surgical Instruments (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne, d’une part, une composition cosmétique destinée à une application sur l’épiderme pour le traitement de l’hyperpigmentation cutanée, caractérisée en ce qu’elle comprend de 1 à 7 doses d’un fluide cryogénique pulvérisé dont la température d’ébullition est comprise entre -196°C et -19°C, chaque dose étant comprise entre 0,048 mL et 0,56 mL et, d’autre part, une méthode de préparation in situ de ladite composition ainsi qu’un procédé de traitement cosmétique utilisant ladite composition. Figure de l’abrégé : Fig. 4
FR2102728A 2021-03-18 2021-03-18 Composition cosmétique destinée au traitement de l’hyperpigmentation cutanée et procédé de traitement utilisant ladite composition Active FR3120792B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR2102728A FR3120792B1 (fr) 2021-03-18 2021-03-18 Composition cosmétique destinée au traitement de l’hyperpigmentation cutanée et procédé de traitement utilisant ladite composition
JP2023556513A JP2024510614A (ja) 2021-03-18 2022-03-15 皮膚の色素沈着の治療を意図した化粧品組成物及び当該組成物を使用する治療方法
MX2023010718A MX2023010718A (es) 2021-03-18 2022-03-15 Composicion cosmetica prevista para el tratamiento de hiperpigmentacion de la piel y metodo de tratamiento que usa la composicion.
US18/550,957 US20240148425A1 (en) 2021-03-18 2022-03-15 Cosmetic composition intended for the treatment of skin hyperpigmentation and treatment method using said composition
CN202280021925.7A CN117157050A (zh) 2021-03-18 2022-03-15 用于治疗皮肤色素沉着的美容组合物和使用该组合物的治疗方法
EP22715023.2A EP4308246A1 (fr) 2021-03-18 2022-03-15 Composition cosmétique destinée au traitement de l'hyperpigmentation cutanée et procédé de traitement utilisant ladite composition
BR112023018573A BR112023018573A2 (pt) 2021-03-18 2022-03-15 Composição cosmética, método para preparar uma composição cosmética, e, uso da composição cosmética
PCT/EP2022/056600 WO2022194810A1 (fr) 2021-03-18 2022-03-15 Composition cosmétique destinée au traitement de l'hyperpigmentation cutanée et procédé de traitement utilisant ladite composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2102728 2021-03-18
FR2102728A FR3120792B1 (fr) 2021-03-18 2021-03-18 Composition cosmétique destinée au traitement de l’hyperpigmentation cutanée et procédé de traitement utilisant ladite composition

Publications (2)

Publication Number Publication Date
FR3120792A1 FR3120792A1 (fr) 2022-09-23
FR3120792B1 true FR3120792B1 (fr) 2024-03-22

Family

ID=77913143

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2102728A Active FR3120792B1 (fr) 2021-03-18 2021-03-18 Composition cosmétique destinée au traitement de l’hyperpigmentation cutanée et procédé de traitement utilisant ladite composition

Country Status (8)

Country Link
US (1) US20240148425A1 (fr)
EP (1) EP4308246A1 (fr)
JP (1) JP2024510614A (fr)
CN (1) CN117157050A (fr)
BR (1) BR112023018573A2 (fr)
FR (1) FR3120792B1 (fr)
MX (1) MX2023010718A (fr)
WO (1) WO2022194810A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100087806A1 (en) * 2008-10-07 2010-04-08 Vandolay, Inc. Automated Cryogenic Skin Treatment
EP3045132A1 (fr) 2015-01-13 2016-07-20 Starpharm Traitement cosmétique des taches brunes cutanées
FR3076200B1 (fr) * 2017-12-28 2023-04-14 Cryobeauty Pharma Buse d'application pour dispositif de traitement dermo-cosmetique des taches brunes cutanees par cryotherapie cyto-selective

Also Published As

Publication number Publication date
FR3120792A1 (fr) 2022-09-23
EP4308246A1 (fr) 2024-01-24
CN117157050A (zh) 2023-12-01
MX2023010718A (es) 2023-10-09
WO2022194810A1 (fr) 2022-09-22
WO2022194810A4 (fr) 2022-11-10
US20240148425A1 (en) 2024-05-09
BR112023018573A2 (pt) 2023-11-28
JP2024510614A (ja) 2024-03-08

Similar Documents

Publication Publication Date Title
Marcum et al. Pharmacotherapies in geriatric chronic pain management
Schott Reflex sympathetic dystrophy
Boonruab et al. The distinction of hot herbal compress, hot compress, and topical diclofenac as myofascial pain syndrome treatment
Gregory et al. Parkinson's disease and the skin
Dawson et al. Acetaminophen use and change in blood pressure in a hypertensive population
FR3120792B1 (fr) Composition cosmétique destinée au traitement de l’hyperpigmentation cutanée et procédé de traitement utilisant ladite composition
Koumaki et al. Palmoplantar pustulosis-like eruption induced by baricitinib for treatment of rheumatoid arthritis
Carroll et al. Management of chronic pain following nerve injuries/CRPS type II
Buntinx et al. Development of an in vivo target‐engagement biomarker for TRPA1 antagonists in humans
Zhang et al. Acupuncture for premature ejaculation: a systematic review and meta-analysis
Li et al. Efficacy of acupuncture and moxibustion in alopecia: a narrative review
Zhu et al. Efficacy of scraping therapy on blood pressure and sleep quality in stage I and II essential hypertension: a systematic review and meta-analysis
Park et al. Review on studies of Korean medicine about tinea pedis
Smirnova et al. Subclinical depression and anxiety as an additional risk factor for cardiovascular events in low-and moderate-risk patients: data from 10-year follow-up
Vishwakarma Homoeopathic management of Acne vulgaris: A case report
Epanchintseva et al. Ejaculate parameters in patients with abdominal obesity
Ben et al. Effect of Trichilia monadelpha (Thonn.) JJ de Wilde (Meliaceae) extracts on C-reactive proteins levels and acute inflammation
Shestakova et al. Prospects of finerenone use in Russian population of patients with chronic kidney disease and type 2 diabetes. Resolution of multidisciplinary. Advisory board
De Jesus et al. Menthol for the Treatment of Erectile Dysfunction: Generation and Technology Export
Gen Scientific African
Del Rosso et al. Management of truncal acne with oral sarecycline: pooled results from two Phase 3 clinical trials
Vaidya et al. ROLE OF MADHUCCHISTADI LEPA IN THE MANAGEMENT OF PADADARI (CRACKED FEET)–A CASE STUDY
Öztürk Botulinum Toxin Treatment in Acne and Seborrhea
Golovanova et al. Early chronic venous disease. What should be done?
Frost et al. P154 Gender and height drive variation between forced vital capacity reference equations: implications for ipf treatment

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20220923

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4